Biotech

ANI Pharmaceuticals Inc (NASDAQ:ANIP) shares rose 2.19% to $53.19 on Monday when the company received approval from the U.S. Food and Drug Administration (FDA) for its Oxcarbazepine tablets. Oxcarbazepine is an antiepileptic drug indicated for use as monotherapy or adjunctive therapy in the treatment of partial seizures in adults. It is...

Eagle Pharmaceuticals Inc (NASDAQ:EGRX) shares were up 27.80% to $53.00 on Friday after the company got wind of a favorable court ruling for its Treanda drug patent. A patent challenge was launched by competitors against this drug that could potentially wiped off significant market share from Eagle Pharmaceuticals. The court ruling validated...

Companies discussed: Biogen Inc (NASDAQ:BIIB), Sarepta Therapeutics Inc (NASDAQ:SRPT), Catabasis Pharmaceuticals Inc (NASDAQ:CATB) Biogen First up, Biogen Inc (NASDAQ:BIIB). Biogen is a little larger than our normal focus range market capitalization here at Small Cap Exclusive, but it’s making waves in the biotech space on the back of some trial data,...

Sarepta Therapeutics Inc (NASDAQ:SRPT) shares rose to $19.67 as of the market close on Tuesday but retreated by 0.10% to $19.65 in after hours trading. The company recently got a request from the FDA for dystrophin data before making a decision on the eteplirsen NDA. A few months back, Sarpeta Therapeutics shares...

LDR Holding Corp (NASDAQ:LDRH) shares scored an additional 0.05% to $37.01 in after hours trading, underscoring the strong bullish momentum. The company received an acquisition offer from Zimmer Biomet Holdings to the tune of $1 billion in cash. This puts the share value of LDR Holding Corp at $37, representing...